Product Name
Strength (w/w)
Specification
Esomeprazole Magnesium EC Pellets
8.5%, 22.5%
IH/USP
Itraconazole IR Pellets
22%, 40%, 44%
IP/BP/USP
Lansoprazole EC Pellets
8.5%
IH/USP
Omeprazole EC Pellets
7.50% 8.5% 15%, 22.5%
IH/USP
Pantoprazole Sodium EC Pellets
15 %, 22.5%
IH/IP
Product Name
Strength (w/w)
Specification
Atorvastatin Calcium IR Pellets
7%, 10 %
USP
Clopidogrel Bisulphate IR Pellets
55%
USP
Domperidone IR Pellets
10%, 20%
IP/IH
Dutasteride IR Pellets
0.32%
USP
Telmisartan IR Pellets
20%
USP
Domperidone SR Pellets
22%
IP/IH
Mebeverine HCl SR Pellets
52.36%
IP/IH
Tamsulosin HCl SR/MR Pellets
0.2%
USP
Esomeprazole Magnesium EC Pellets
8.5%, 22.5%
USP
Lansoprazole EC Pellets
‘8.5%
USP
Omeprazole EC Pellets
7.50%, 8.50%, , 15%, 22.50%, 30%
USP
Pantoprazole Sodium EC Pellets
15%, 22.5%, 30%
IP
Rabeprazole Sodium EC Pellets
15%
IP/IH
Product Name
Strength (w/w)
Specification
Esomeprazole Magnesium Delayed Release
8.5%, 22.5%
USP
Itraconazole Immediate Release
22%.
BP
Lansoprazole Delayed Release
‘8.5%
USP
Omeprazole Delayed Release
‘8.5%
USP
Pantoprazole Sodium Delayed Release
15%
IP
Product Name
Strength (w/w)
Specification
Pantoprazole Sodium EC + Domperidone SR
40 mg & 30 mg
IP
Rabeprazole Sodium EC + Domperidone SR
20 mg & 30 mg
IP
Omeprazole EC + Domperidone IR
20 mg & 10 mg
IP
Atorvastatin IR + Clopidogrel IR
10 mg & 75 mg
IH
Tamsulosin HCl SR + Dutasteride IR
0.4 mg & 0.5 mg
IP
Product Name
Strength (w/w)
Specification
Guaifenesin
95%
USP
Guaifenesin ER
94.9%
USP
Metformin HCl
94.16%, 95.24%.
USP
Paracetamol /Acetaminophen
79.37%, 90 %, 83.33%.
USP
Paracetamol / Acetaminophen ER
88%
USP
Product Name
Strength (w/w)
Specification
Esomeprazole Magnesium EC /DR Pellets
8.50%, 15%, 22.5%, 23.5%
USP/IH
Itraconazole IR Pellets
20%, 22%, 40%, 44%
USP/BP/IH
Lansoprazole EC/DR Pellets
‘8.5%
USP/IH
Omeprazole EC /DR Pellets
7.5%, 8.5%, 15%, 22.5%
USP/IH
Pantoprazole Sodium EC/DR Pellets
15%, 22.5%
IP/IH
Product Name
Strength (w/w)
Specification
Dexlansoprazole DDR Pellets
20%, 22.5%
IH
Duloxetine HCl EC/DR Pellets
11%,
IH
Orlistat IR Pellets
40%, 50%
USP
Tamsulosin HCl SR Pellets
0.16%
USP
Tamsulosin HCl SR MUPS
0.16%
USP
Product Name
Strength (w/w)
Specification
Guaifenesin IR
55%
IH
Paracetamol MR
84%
USP
Metformin ER
58%
USP
IR: Immediate Release | ER: Extented Release | SR: Sustained Release | MR: Modified Release | EC: Entric Coated | DDR: Dual Delayed Release
Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufacturing Active Pharmaceutical Ingredients, API Intermediates and NDDS/Pellets for the generics market across the world.
Smilax Laboratories Limited
12th Floor, Ramky Grandiose Towers Opp. Rolling Hills, Mind Space Road Janardhan Reddy Nagar, Gachibowli Hyderabad – 500 032, Telangana, India
Smilax Laboratories Limited
Plot No: 12/A, Phase – Ill, IDA, Jeedimetla, Hyderabad – 500 055, Telangana, India
© 2024 – All Rights Reserved